JP2022515884A5 - - Google Patents

Info

Publication number
JP2022515884A5
JP2022515884A5 JP2021538386A JP2021538386A JP2022515884A5 JP 2022515884 A5 JP2022515884 A5 JP 2022515884A5 JP 2021538386 A JP2021538386 A JP 2021538386A JP 2021538386 A JP2021538386 A JP 2021538386A JP 2022515884 A5 JP2022515884 A5 JP 2022515884A5
Authority
JP
Japan
Application number
JP2021538386A
Other languages
Japanese (ja)
Other versions
JP2022515884A (ja
JP7657152B2 (ja
JPWO2020141459A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000018 external-priority patent/WO2020141459A1/en
Publication of JP2022515884A publication Critical patent/JP2022515884A/ja
Publication of JPWO2020141459A5 publication Critical patent/JPWO2020141459A5/ja
Publication of JP2022515884A5 publication Critical patent/JP2022515884A5/ja
Priority to JP2024178721A priority Critical patent/JP2025020143A/ja
Application granted granted Critical
Publication of JP7657152B2 publication Critical patent/JP7657152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021538386A 2019-01-03 2020-01-03 切断可能なリンカーを含む化合物及びその使用 Active JP7657152B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024178721A JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962788013P 2019-01-03 2019-01-03
US62/788,013 2019-01-03
PCT/IB2020/000018 WO2020141459A1 (en) 2019-01-03 2020-01-03 Compounds comprising cleavable linker and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024178721A Division JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Publications (4)

Publication Number Publication Date
JP2022515884A JP2022515884A (ja) 2022-02-22
JPWO2020141459A5 JPWO2020141459A5 (https=) 2023-01-19
JP2022515884A5 true JP2022515884A5 (https=) 2023-01-19
JP7657152B2 JP7657152B2 (ja) 2025-04-04

Family

ID=71407393

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021538386A Active JP7657152B2 (ja) 2019-01-03 2020-01-03 切断可能なリンカーを含む化合物及びその使用
JP2024178721A Withdrawn JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024178721A Withdrawn JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Country Status (11)

Country Link
US (1) US20220118104A1 (https=)
EP (1) EP3906064A4 (https=)
JP (2) JP7657152B2 (https=)
KR (1) KR20210099660A (https=)
CN (2) CN113453726A (https=)
AU (1) AU2020205160A1 (https=)
BR (1) BR112021012365A2 (https=)
CA (1) CA3124758A1 (https=)
EA (1) EA202191854A1 (https=)
MX (1) MX2021008095A (https=)
WO (1) WO2020141459A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019008441A1 (en) 2017-07-04 2019-01-10 Intocell, Inc. COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF
WO2020141460A2 (en) 2019-01-03 2020-07-09 Intocell, Inc. Compounds comprising cleavable linker and uses thereof
IL322315A (en) 2019-05-14 2025-09-01 Provention Bio Inc Methods and preparations for preventing type 1 diabetes
AU2021287998B2 (en) 2020-06-11 2026-03-12 Benaroya Research Institute At Virginia Mason Methods and compositions for preventing type 1 diabetes
US12565529B2 (en) 2021-05-24 2026-03-03 Provention Bio, Inc. Methods for treating type 1 diabetes
WO2025237246A1 (en) * 2024-05-11 2025-11-20 Westlake Laboratory Of Life Sciences And Biomedicine Novel covalent protein and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105899539B (zh) * 2014-01-10 2021-11-09 博笛生物科技有限公司 用于免疫疗法的化合物和组合物
KR101628872B1 (ko) * 2014-05-28 2016-06-09 주식회사 레고켐 바이오사이언스 자가-희생 기를 포함하는 화합물
CN107922375B (zh) * 2015-07-30 2020-05-22 正大天晴药业集团股份有限公司 靶向idh2突变的抗肿瘤化合物及其使用方法
KR101766822B1 (ko) * 2015-09-10 2017-08-24 서울대학교산학협력단 디페닐설페이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 c형 간염 바이러스 관련 질환의 예방 또는 치료용 약학적 조성물
WO2018124758A2 (ko) * 2016-12-28 2018-07-05 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
WO2019008441A1 (en) * 2017-07-04 2019-01-10 Intocell, Inc. COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF
MX2020012718A (es) * 2018-05-29 2021-02-16 Intocell Inc Derivados de benzodiazepinas novedosos y usos de los mismos.
KR20210068591A (ko) * 2018-10-31 2021-06-09 주식회사 인투셀 융합된 헤테로시클릭 벤조디아제핀 유도체 및 그의 용도

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)